Vorinostat Completed Phase 2 Trials for Recurrent Prostate Cancer / Stage IV Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00330161Vorinostat in Treating Patients With Progressive Metastatic Prostate Cancer